Tim Illidge Selected Research

Neoplasms (Cancer)

1/2020	Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma.
1/2019	Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
1/2019	Clinical Development of Novel Drug-Radiotherapy Combinations.
11/2016	Immunotherapy with radiotherapy in urological malignancies.
10/2016	Clinical development of new drug-radiotherapy combinations.
11/2015	Obinutuzumab in hematologic malignancies: lessons learned to date.
3/2015	Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
10/2014	Update on obinutuzumab in the treatment of B-cell malignancies.
7/2014	Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
6/2011	Radioimmunotherapy in follicular lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Illidge Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 01/2004
15	Lymphoma (Lymphomas) 11/2021 - 08/2006
14	Hodgkin Disease (Hodgkin's Disease) 11/2021 - 04/2013
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 02/2008
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 02/2008
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018 - 06/2012
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 02/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 02/2007
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019 - 10/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 12/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2011 - 07/2007
1	Oropharyngeal Neoplasms 10/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Infections 01/2020
1	COVID-19 01/2020
1	Anemia 01/2018
1	Diarrhea 01/2018
1	Leukopenia 01/2018
1	Kidney Neoplasms (Kidney Cancer) 11/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2015
1	Disease Progression 04/2015
1	Hemorrhage 07/2007
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2006
1	Brain Neoplasms (Brain Tumor) 01/2004

Drug/Important Bio-Agent (IBA)

9	Brentuximab VedotinIBA 01/2019 - 06/2012
7	Monoclonal AntibodiesIBA 01/2020 - 08/2005
6	Rituximab (Mabthera)FDA Link 01/2020 - 02/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 10/2014
4	Prednisone (Sone)FDA LinkGeneric 01/2019 - 10/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 10/2014
3	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 10/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019 - 04/2015
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 04/2015
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 04/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 12/2017 - 03/2015
2	obinutuzumabIBA 11/2015 - 10/2014
2	Yttrium-90IBA 07/2007 - 08/2006
2	ibritumomab tiuxetan (Zevalin)FDA Link 07/2007 - 08/2006
1	B7-H1 AntigenIBA 11/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Procarbazine (Matulane)FDA Link 01/2019
1	AntigensIBA 02/2007
1	AntibodiesIBA 02/2007
1	CD20 AntigensIBA 08/2006
1	Complement System Proteins (Complement)IBA 08/2005
1	motexafin gadoliniumIBA 01/2004

Therapy/Procedure

19	Radiotherapy 10/2022 - 01/2004
12	Therapeutics 11/2021 - 08/2006
8	Drug Therapy (Chemotherapy) 10/2022 - 08/2008
6	Radioimmunotherapy 01/2020 - 08/2006
2	Stem Cell Transplantation 01/2018 - 07/2007
2	Immunotherapy 11/2016 - 02/2008
1	Image-Guided Radiotherapy 07/2014
1	Homologous Transplantation 04/2013
1	Combined Modality Therapy 07/2011
1	Induction Chemotherapy 02/2008